The Analyst Verdict: Inspire Medical Systems In The Eyes Of 7 Experts
Portfolio Pulse from Benzinga Insights
Inspire Medical Systems (NYSE:INSP) has been evaluated by 7 analysts over the past three months, with a mix of bullish and bearish opinions. The average 12-month price target has decreased by 10.51% to $212.86. Analysts have adjusted their ratings and price targets in response to market conditions and company performance. Despite positive revenue growth, the company faces challenges with net margin and return on equity.
September 10, 2024 | 6:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Inspire Medical Systems has received mixed analyst ratings, with a decrease in the average 12-month price target to $212.86. Analysts have adjusted their ratings and price targets, reflecting changing market conditions and company performance. Despite strong revenue growth, the company faces challenges with net margin and return on equity.
The mixed analyst ratings and the decrease in the average price target suggest a neutral short-term impact on INSP's stock price. While the company shows strong revenue growth, challenges in profitability metrics like net margin and ROE may offset positive sentiment. The adjustments in ratings and price targets by analysts indicate a cautious outlook.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100